Health Care & Life Sciences » Pharmaceuticals | Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
647,109.50
473,964.70
618,194.70
710,494.10
925,201.00
Cost of Goods Sold (COGS) incl. D&A
630,927.00
456,718.90
596,654.20
667,059.10
836,300.00
Gross Income
16,182.50
17,245.80
21,540.50
43,435.00
88,901.00
SG&A Expense
12,950.50
9,767.80
13,585.00
12,952.90
33,521.00
EBIT
2,712.00
7,324.50
7,548.50
30,286.90
55,380.00
Unusual Expense
-
-
41.70
-
-
Non Operating Income/Expense
6,774.90
1,580.00
920.40
196.00
2,457.00
Interest Expense
7,533.80
5,854.60
5,085.60
6,772.70
8,635.00
Pretax Income
4,074.70
4,790.60
4,487.20
24,933.30
49,202.00
Income Tax
1,656.20
1,630.70
1,474.00
9,277.60
17,035.00
Consolidated Net Income
2,418.40
3,159.90
3,013.20
15,655.70
32,167.00
Net Income
2,418.40
3,159.90
3,013.20
15,655.70
32,167.00
Net Income After Extraordinaries
2,418.40
3,159.90
3,013.20
15,655.70
32,167.00
Net Income Available to Common
2,418.40
3,159.90
3,013.20
15,655.70
32,167.00
EPS (Basic)
0.78
1.02
0.98
5.07
10.41
Basic Shares Outstanding
3,089.70
3,089.70
3,089.70
3,089.70
-
EPS (Diluted)
0.78
1.02
0.98
5.07
-
Diluted Shares Outstanding
3,089.70
3,089.70
3,089.70
3,089.70
-
EBITDA
6,020.60
11,700.00
11,982.20
37,234.90
59,502.00
Other Operating Expense
519.90
153.50
407.00
195.20
-
Non-Operating Interest Income
2,121.50
1,740.70
1,145.50
452.80
-

About Samrat Pharmachem

View Profile
Address
701/702, Business Square
Mumbai Maharashtra 400058
India
Employees -
Website http://www.samratpharmachem.com
Updated 09/14/2018
Samrat Pharmachem Ltd. engages in the manufacture of iodine and bromine salts. Its products include 3-5-Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, and barium, copper, and zinc iodide. The company was founded by Lalit Damodar Mehta on June 16, 1992 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.